Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 6060 clinical trials
Featured trial
Migraine Study for Men or Women ages 18 to 65 Currently Using Triptans. (e.g., Almotriptan/Axert; Frovatriptan/Frova; Rizatriptan/Maxalt; Sumatriptan/Imitrex; Zolmitriptan/Zomig)

Migraine Study for Men or Women ages 18 to 65 Currently Using Triptans. (e.g., Almotriptan/Axert; Frovatriptan/Frova; Rizatriptan/Maxalt; Sumatriptan/Imitrex; Zolmitriptan/Zomig)

  • 406 views
  • 08 Nov, 2020
  • 1 location
Featured trial
(OSKIRA): A Phase III, Multi-centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of Two Dosing Regimens of Investigational Product (Oral Agents) in Rheumatoid Arthritis Patients.

(OSKIRA): A Phase III, Multi-centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of Two Dosing Regimens of Investigational Product (Oral Agents) in Rheumatoid Arthritis Patients.

  • 204 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Do you think you're having difficulty controlling your high blood pressure?

Do you think you're having difficulty controlling your high blood pressure?

  • 467 views
  • 08 Nov, 2020
  • 1 location
Featured trial
A Phase Ii, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of Ro4602522 Added To The Background Therapy Of The Acetylcholinesterase Inhibitors Donepezil Or Rivastigmine In Patients With Moderate Severity Alzheimer's Disease

A Phase Ii, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of Ro4602522 Added To The Background Therapy Of The Acetylcholinesterase Inhibitors Donepezil Or Rivastigmine In Patients With Moderate Severity Alzheimer's Disease

  • 153 views
  • 25 Mar, 2021
  • 1 location
Featured trial
Ph 2a study of CY6463 in participants with Alzheimer’s disease and vascular pathology

This study is being conducted to evaluate an oral investigational drug called CY6463 in individuals 60 years of age and older who have Alzheimer’s disease (AD) and common cardiovascular risk factors such as high blood pressure, diabetes, high cholesterol, and/or elevated body mass. The main goals of this study are to …

mental state examination
dementia
mini-mental state examination
alzheimer's disease
  • 0 views
  • 23 Jun, 2022
  • 5 locations
Featured trial
Do you suffer from Hemorrhoids?

Do you suffer from Hemorrhoids?

  • 1549 views
  • 25 Mar, 2021
  • 1 location
A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD)

The purpose of this study is to characterize the distribution of lipoprotein(a) (Lp(a)) levels among participants with a history of ASCVD as defined by their medical history and is 2-fold:

  • 0 views
  • 15 Jun, 2022
  • 51 locations
Effects of Statin for Elderly Patients With Atherosclerotic Cardiovascular Disease

High-dose statins can reduce mortality and cardiovascular events in patients with established atherosclerotic cardiovascular disease (ASCVD). Therefore, US and European recommendations recommend

ezetimibe
hmg-coa reductase inhibitors
cardiovascular disease
LDL Cholesterol
rosuvastatin
  • 0 views
  • 12 Dec, 2021
  • 2 locations
Cardiovascular Disease Prevention in Europe and Sub-Saharan Africa (Spices_phase_2)

Cardiovascular disease (CVD) is the leading cause of death in the world. 17.5 million people died in 2012 due to CVD (31% of all causes of death). In Europe more than 50% of deaths are due to

  • 0 views
  • 28 Feb, 2022
  • 1 location
STREAM Trial - Statins in Multimorbid Older Adults Without Cardiovascular Disease (STREAM)

Statins are among the most widely used drugs. While they were found to be effective for primary and secondary prevention of cardiovascular disease (CVD) in middle-aged subjects, their benefits

  • 0 views
  • 24 Mar, 2022